News shared by:

336 Articles
01 Sep 2019
Allergan shifts opioid blame on to Teva

Pharmaceutical company Allergan, which sold Actavis, its generic drug division, to Teva Pharmaceutical Industries Ltd. , is blaming the Israeli company in the lawsuits filed in the opioid...

01 Sep 2019
Better Buy - Gilead Sciences and Biogen

Gilead Sciences continues to plod along with its stock range-bound throughout the year. The big biotech did, however, return to revenue growth after a long stretch of declining sales. Biogen,...

30 Aug 2019
Key Pharmaceuticals acquired by Lexon Group of companies

Cambridgeshire based Key Pharmaceuticals, a specialist in development, licensing and support of innovative generics, has been acquired by the Lexon Group of companies. The Lexon Group, which...

30 Aug 2019
IV All-Russian GMP-conference

The full formal program of the event was published on the official website of the IV All-Russian GMP-conference with international participation. The role of the pharmaceutical industry in the...

28 Aug 2019
Amgen to buy Otezla from Celgene

Amgen has signed an agreement with Celgene to acquire Otezla (apremilast) medicine for $13.4bn in cash or around $11.2bn net of estimated cash tax benefits in the future. The deal covers...

28 Aug 2019
5 pharma companies have filed a complaint in Canadian court

Five pharmaceutical companies have announced they have filed a complaint in a Canadian court challenging the constitutionality of new regulations in the country. The rulings were part of an effort...

Block ?

If this page is in your subscriptions, then it will be removed. You will not see this page. If you want to unblock a user, go to the settings, the list of blocked users and click unblock

Complain

The user will not know who exactly sent the complaint

Delete Company

The user will not know who exactly sent the complaint

Notifications

You Have 112 readed notifications

CHATS

Select chat category

×